| Angie J Whitesell, MD | |
|
1307 Main Street, Lockwood, MO 65682 | |
| (417) 232-4560 | |
| (417) 232-4611 |
| Full Name | Angie J Whitesell |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 22 Years |
| Location | 1307 Main Street, Lockwood, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689679391 | NPI | - | NPPES |
| 431560263 | Other | TRICARE WEST | |
| 207274408 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2003014018 (Missouri) | Primary |
| 207V00000X | Obstetrics & Gynecology | 2003014018 (Missouri) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Avalon Hospice | Joplin, MO | Hospice |
| Mercy Hospital Springfield | Springfield, MO | Hospital |
| Mercy Hospital Carthage | Carthage, MO | Hospital |
| Mercy Hospital - Aurora | Aurora, MO | Hospital |
| Good Shepherd Community Care And Rehabilitation | Lockwood, MO | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Clinic Springfield Communities | 7416865845 | 922 |
News Archive
The rapidly emerging field of precision medicine is a "disruptive innovation" that offers the possibility of remarkably fine-tuned remedies to improve patient health while minimizing the risk of harmful side effects, says J. Larry Jameson, MD, PhD, dean of the Perelman School of Medicine and executive vice president of the University of Pennsylvania for the Health System, in this week's issue of the New England Journal of Medicine.
Early-stage human clinical trials showed that a new topical drug was safe and had biological effects in a type of diabetic eye disease, and may offer researchers a new approach to prevent and treat diabetic macular edema.
Can a gene simultaneously protect against cancer and favor its growth? Researchers at the Spanish National Cancer Research Centre have discovered a gene with this double-edged property and suspect there may be many more that share it. In the words of Oscar Fernandez Capetillo, head of the group responsible for the study, this gene "can be both Dr. Jekyll and Mr. Hyde, in that it can either protect us against the appearance of tumors or promote tumor growth".
New research indicates that low levels of a growth factor called stem cell factor (SCF)-which is thought to be important for blood vessel repair-are linked with an increased risk of cardiovascular disease.
› Verified 4 days ago
| Entity Name | Mercy Clinic Springfield Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245277631 PECOS PAC ID: 7416865845 Enrollment ID: O20031104000060 |
News Archive
The rapidly emerging field of precision medicine is a "disruptive innovation" that offers the possibility of remarkably fine-tuned remedies to improve patient health while minimizing the risk of harmful side effects, says J. Larry Jameson, MD, PhD, dean of the Perelman School of Medicine and executive vice president of the University of Pennsylvania for the Health System, in this week's issue of the New England Journal of Medicine.
Early-stage human clinical trials showed that a new topical drug was safe and had biological effects in a type of diabetic eye disease, and may offer researchers a new approach to prevent and treat diabetic macular edema.
Can a gene simultaneously protect against cancer and favor its growth? Researchers at the Spanish National Cancer Research Centre have discovered a gene with this double-edged property and suspect there may be many more that share it. In the words of Oscar Fernandez Capetillo, head of the group responsible for the study, this gene "can be both Dr. Jekyll and Mr. Hyde, in that it can either protect us against the appearance of tumors or promote tumor growth".
New research indicates that low levels of a growth factor called stem cell factor (SCF)-which is thought to be important for blood vessel repair-are linked with an increased risk of cardiovascular disease.
› Verified 4 days ago
| Entity Name | Mercy Clinic Springfield Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972771657 PECOS PAC ID: 7416865845 Enrollment ID: O20031218000354 |
News Archive
The rapidly emerging field of precision medicine is a "disruptive innovation" that offers the possibility of remarkably fine-tuned remedies to improve patient health while minimizing the risk of harmful side effects, says J. Larry Jameson, MD, PhD, dean of the Perelman School of Medicine and executive vice president of the University of Pennsylvania for the Health System, in this week's issue of the New England Journal of Medicine.
Early-stage human clinical trials showed that a new topical drug was safe and had biological effects in a type of diabetic eye disease, and may offer researchers a new approach to prevent and treat diabetic macular edema.
Can a gene simultaneously protect against cancer and favor its growth? Researchers at the Spanish National Cancer Research Centre have discovered a gene with this double-edged property and suspect there may be many more that share it. In the words of Oscar Fernandez Capetillo, head of the group responsible for the study, this gene "can be both Dr. Jekyll and Mr. Hyde, in that it can either protect us against the appearance of tumors or promote tumor growth".
New research indicates that low levels of a growth factor called stem cell factor (SCF)-which is thought to be important for blood vessel repair-are linked with an increased risk of cardiovascular disease.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Angie J Whitesell, MD 1307 N Main St, Nevada, MO 64772-1129 Ph: (417) 232-4560 | Angie J Whitesell, MD 1307 Main Street, Lockwood, MO 65682 Ph: (417) 232-4560 |
News Archive
The rapidly emerging field of precision medicine is a "disruptive innovation" that offers the possibility of remarkably fine-tuned remedies to improve patient health while minimizing the risk of harmful side effects, says J. Larry Jameson, MD, PhD, dean of the Perelman School of Medicine and executive vice president of the University of Pennsylvania for the Health System, in this week's issue of the New England Journal of Medicine.
Early-stage human clinical trials showed that a new topical drug was safe and had biological effects in a type of diabetic eye disease, and may offer researchers a new approach to prevent and treat diabetic macular edema.
Can a gene simultaneously protect against cancer and favor its growth? Researchers at the Spanish National Cancer Research Centre have discovered a gene with this double-edged property and suspect there may be many more that share it. In the words of Oscar Fernandez Capetillo, head of the group responsible for the study, this gene "can be both Dr. Jekyll and Mr. Hyde, in that it can either protect us against the appearance of tumors or promote tumor growth".
New research indicates that low levels of a growth factor called stem cell factor (SCF)-which is thought to be important for blood vessel repair-are linked with an increased risk of cardiovascular disease.
› Verified 4 days ago
Dr. Beverly A. Holmes, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1307 S Main St, Route 3, Box 25, Lockwood, MO 65682 Phone: 417-232-4560 Fax: 417-232-4611 | |
Dr. Travis Tyler Hawks, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1307 S Main St, Lockwood, MO 65682 Phone: 417-232-4560 |